Skip to content

Clinical trials

Terminated Lymphoma, Follicular trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Status: Terminated Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20132
20151
20161
20171
20182
20192
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences2
MEI Pharma, Inc.2
Pfizer2
Regeneron Pharmaceuticals2
Hoffmann-La Roche1
IGM Biosciences, Inc.1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
Oppilan Pharma Ltd1
TG Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular14
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Non-Hodgkin5
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Mantle-Cell4
Leukemia, Lymphocytic, Chronic, B-Cell3
Dermatitis, Atopic2
Waldenstrom Macroglobulinemia2
Bronchiolitis Obliterans Syndrome1
Colitis, Ulcerative1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.